The Spine Phenome Project: Enhancing Patient Diversity

脊柱表型组项目：增强患者多样性

• 批准号: 10616220
• 负责人: Safdar N. Khan
• 金额: $ 51.22万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-26 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10616220
• 关键词: Address; Administrative Supplement; Adult; Advocate; Affect; Appalachian Region; Asian population; Back Pain; Biological Markers; Black Populations; Caring; Chronic low back pain; Clinical Research; Communication; Communities; Community Healthcare; Community Outreach; Complex; Data; Data Set; Diagnosis; Diagnostic; Diagnostic Errors; Disease Progression; Enrollment; Ensure; Evaluation; Fostering; Funding; Future; Geography; Grant; Health; Health Personnel; Hispanic Populations; Individual; Information Dissemination; Interdisciplinary Study; Intervention; Interventional Imaging; Measures; Medical Care Costs; Minority Groups; Morals; Motion; Ohio; Opioid; Outcome; Pain; Parents; Participant; Patient Outcomes Assessments; Patient Recruitments; Patient-Focused Outcomes; Patients; Persons; Phenotype; Prevalence; Provider; Reduce health disparities; Research; Research Personnel; Rural; Rural Appalachia; Rural Population; Site; Societies; Treatment outcome; Trust; Underrepresented Populations; Underserved Population; United States National Institutes of Health; Vertebral column; Work; addiction; biopsychosocial; chronic painful condition; clinical decision-making; clinical practice; community clinic; community engagement; cost; digital; disability; diversity and inclusion; ethnic diversity; ethnic minority; ethnic minority population; functional disability; health equity; imaging modality; improved; individual patient; novel; opioid epidemic; opioid use; outreach; outreach program; pain outcome; pain patient; parent grant; patient population; personalized medicine; phenome; precision medicine; prescription opioid; racial and ethnic; racial diversity; racial minority; recruit; research study; retention rate; social determinants; treatment trial; wearable sensor technology

Project Summary/Abstract Chronic Low Back Pain (cLBP) is a debilitating condition that affects millions of people globally. Despite increased utilization of interventions and rising medical costs, cLBP prevalence has continued to increase. This problem arises because cLBP is complex, heterogeneous and current diagnostics and treatments rely primarily on subjective metrics and do not target all the multidimensional biopsychosocial mechanisms associated with cLBP. To address this problem, we have a NIH Back Pain Consortium (BACPAC) grant to conduct a longitudinal research study to identify unique cLBP phenotypes and inform personalized medicine to improve patient outcomes. In addition, we are also collaborating in a multi-site NIH BACPAC BEST (Biomarkers for Evaluating Spine Treatments) Trial to inform precision medicine approach for the treatment of cLBP patients. A total of 480 cLBP patients are anticipated to be enrolled over a 3-year period between these two studies. However, in order to ensure that our study findings are generalizable and meaningful to all individuals with cLBP, our patient population needs to be diverse, inclusive and representative. It is well documented that minority groups in general are underrepresented in clinical studies. It is therefore critical and important to enhance patient diversity and inclusion in our efforts particularly in relation to the fact that social determinants to health are known to differentially impact cLBP outcomes. Furthermore, enhancing patient diversity is not only a scientific imperative but also a moral one, as it will help reduce health disparities and improve health equity for the treatment of cLBP in our society. Collectively, the proposed effort helps ensure that our findings are derived from a diverse and representative data sets and has the potential to shift clinical practice paradigms, improve patient outcomes, enhance care efficiency, and reduce costs.

项目总结/文摘